INPX, ATNF and REUN Are Among Pre Market Gainers
Top Premarket Gainers
Q3 2023 EPS Estimates for Reunion Neuroscience Inc. (NASDAQ:REUN) Raised by Analyst
Reunion Neuroscience Inc. (NASDAQ:REUN – Get Rating) – Stock analysts at HC Wainwright raised their Q3 2023 earnings estimates for shares of Reunion Neuroscience in a research note issued to invest
Reunion Neuroscience (TSE:REUN) Earns "Buy" Rating From HC Wainwright
HC Wainwright restated their buy rating on shares of Reunion Neuroscience (TSE:REUN – Get Rating) in a research report report published on Thursday morning. The brokerage currently has a C$20.00 pri
Reunion Neuroscience (TSE:REUN) Stock Rating Reaffirmed by HC Wainwright
Reunion Neuroscience (TSE:REUN – Get Rating)'s stock had its "buy" rating reiterated by investment analysts at HC Wainwright in a research report issued on Thursday. They presently have a C$20.00 tar
H.C. Wainwright Remains a Buy on Reunion Neuroscience (REUN)
Reunion Neuroscience Names Robert Alexander Chief Medical Officer
Reunion Neuroscience Appoints Robert Alexander as Chief Medical Officer
TORONTO, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (NASDAQ:REUN, TSX:REUN) ("Reunion" or "the Company"), a biopharmaceutical company committed to developing innovative and patented therapeutic
Reunion Neuroscience (TSE:REUN) Investors Are Sitting on a Loss of 74% If They Invested a Year Ago
Reunion Neuroscience (NASDAQ:REUN) Shares Up 4.5%
Shares of Reunion Neuroscience Inc. (NASDAQ:REUN – Get Rating) shot up 4.5% during trading on Friday . The stock traded as high as $1.44 and last traded at $1.41. 54,642 shares changed hands during m